Explore / Clinical trial
Clinical trial

Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients

Pusan National University Yangsan HospitalTerminatedPhase 2Started Jun 1, 201820 enrolledSouth KoreaNCT03362073

Abstract

To establish the role of ketamine in hospitalized terminally ill cancer patients with refractory cancer pain, using continuous intravenous infusion of ketamine

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePainPalliative care

Keywords

Refractory cancer painTerminally ill cancer patientsRefractory Cancer Pain

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.